- Role
- Country
- Date of registration
- Address
Page 2 of 7 — Products 26–50 of 173
| Product | Trade name | Reference / catalog number | Quantity | Status | |
|---|---|---|---|---|---|
| i-Tracker Anti-Infliximab Total Ab | i-Tracker Anti-Infliximab Total Ab | CTI 003T-50 | 03532672000240 | 1 | On the market |
| i-Tracker Anti-Ocrelizumab | i-Tracker Anti-Ocrelizumab | CTO 003-50 | 03532672000219 | 1 | On the market |
| i-Tracker Anti-Risankizumab | i-Tracker Anti-Risankizumab | CTRZ 003-50 | 03532672000172 | 1 | On the market |
| i-Tracker Anti-Rituximab | i-Tracker Anti-Rituximab | CTR 003-50 | 03532672000158 | 1 | On the market |
| i-Tracker Anti-Ustekinumab |
| i-Tracker Anti-Ustekinumab |
CTU 003-50 |
03532672000059 |
| 1 |
| On the market |
| i-Tracker Anti-Vedolizumab | i-Tracker Anti-Vedolizumab | CTV 003-50 | 03532672000073 | 1 | On the market |
| i-Tracker Certolizumab | i-Tracker Certolizumab | CTC 002-50 | 03532672000080 | 1 | On the market |
| i-Tracker Etanercept | i-Tracker Etanercept | CTE 002-50 | 03532672000103 | 1 | On the market |
| i-Tracker Golimumab | i-Tracker Golimumab | CTG 002-50 | 03532672000127 | 1 | On the market |
| i-Tracker Infliximab | i-Tracker Infliximab | CTI 002-100 | 03532672000028 | 1 | On the market |
| i-Tracker Ocrelizumab | i-Tracker Ocrelizumab | CTO 002-50 | 03532672000202 | 1 | On the market |
| i-Tracker Risankizumab | i-Tracker Risankizumab | CTRZ 002-50 | 03532672000165 | 1 | On the market |
| i-Tracker Rituximab | i-Tracker Rituximab | CTR 002-50 | 03532672000141 | 1 | On the market |
| i-Tracker Ustekinumab | i-Tracker Ustekinumab | CTU 002-50 | 03532672001964 | 1 | On the market |
| i-Tracker Vedolizumab | i-Tracker Vedolizumab | CTV 002-50 | 03532672000066 | 1 | On the market |
| IMMUNO-TROL Golimumab | IMMUNO-TROL Golimumab | LTG 002-PC | 03532672001025 | 1 | On the market |
| IMMUNO-TROL Adalimumab | IMMUNO-TROL Adalimumab | LTA 002-PC | 03532672000882 | 1 | On the market |
| IMMUNO-TROL Anti- Golimumab | IMMUNO-TROL Anti- Golimumab | LTG 003-PC | 03532672001032 | 1 | On the market |
| IMMUNO-TROL Anti-Adalimumab | IMMUNO-TROL Anti-Adalimumab | LTA 003-PC | 03532672000899 | 1 | On the market |
| IMMUNO-TROL Anti-Bevacizumab | IMMUNO-TROL Anti-Bevacizumab | LTB 003-PC | 03532672001117 | 1 | On the market |
| IMMUNO-TROL Anti-Certolizumab | IMMUNO-TROL Anti-Certolizumab | LTC 003-PC | 03532672000912 | 1 | On the market |
| IMMUNO-TROL Anti-Etanercept | IMMUNO-TROL Anti-Etanercept | LTE 003-PC | 03532672001018 | 1 | On the market |
| IMMUNO-TROL Anti-Infliximab | IMMUNO-TROL Anti-Infliximab | LTI 003-PC | 03532672000936 | 1 | On the market |
| IMMUNO-TROL Anti-Rituximab | IMMUNO-TROL Anti-Rituximab | LTR 003-PC | 03532672001056 | 1 | On the market |
| IMMUNO-TROL Anti-Secukinumab | IMMUNO-TROL Anti-Secukinumab | LTS 003-PC | 03532672000998 | 1 | On the market |
Primary DI
The Primary DI is the main UDI-DI a manufacturer designates as the principal identifier for a device in EUDAMED.
View in glossary →